<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04982822</url>
  </required_header>
  <id_info>
    <org_study_id>202004072RINA</org_study_id>
    <nct_id>NCT04982822</nct_id>
  </id_info>
  <brief_title>Novel Senhance Robotic System in Urologic Surgery: Its Clinical Application and Implication</brief_title>
  <official_title>Novel Senhance Robotic System in Urologic Surgery: Its Clinical Application and Implication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observational study to collect data from the participants who received urologic surgeries&#xD;
      using the Senhance Robotic system.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational study and investigators will collect peri-operative and demographic&#xD;
      data from the participants who received minimal invasive surgeries using Senhance robotic&#xD;
      system in the National Taiwan University Hospital Yunlin Branch, Urology Department. The&#xD;
      investigators want to demonstrate if the robotic system is safe and feasible in urologic&#xD;
      laparoscopic surgeries.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Peri-operative complications</measure>
    <time_frame>postoperative 30 days</time_frame>
    <description>Using Clavien-Dindo classification to record the safety outcome</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Urologic Diseases</condition>
  <condition>Surgery</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study populations consisted of aged from 18 years old to 90 years old and had will to&#xD;
        receive laparoscopic surgeries using the Senhance robotic system.&#xD;
&#xD;
        The were excluded if there's major severe cardio-pulmonary condition or had received&#xD;
        extensive abdominal surgeries.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Patients undergo laparoscopic urologic surgeries&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>LunHsiang Yuan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital Yunlin Branch</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>LunHsiang Yuan, MD</last_name>
    <phone>0921254585</phone>
    <email>lunhsiang.yuan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ShiWei Huang</last_name>
    <phone>0972655725</phone>
    <email>will6438.huang@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <state>Outside U.S./Canada</state>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ShiWei Huang, MD</last_name>
      <phone>0972655725</phone>
      <email>will6438.huang@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 23, 2021</study_first_submitted>
  <study_first_submitted_qc>July 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2021</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Urology</keyword>
  <keyword>Senhance</keyword>
  <keyword>Robotic surgical system</keyword>
  <keyword>Laparoscopic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urologic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

